26 results
Thumbnail

D1.428 - Fungal Microbiome Diversity in Urban Forest Decreases Asthma and Allergic Inflammation

Thumbnail

D1.431 - Associations of the composition of intestinal microbiota with the initial manifestations of IgE-mediated food allergy in children 6-12 months old

Thumbnail

D1.433 - The effect of preventive administration of probiotic strain E. coli 083:H24:K31 on selected immune characteristics of eight-year-old children

Thumbnail

D2.33 - Correlation of chronic rhinosinusitis and lung function in allergy patients with chronic cough

Thumbnail

D2.34 - Generalized allergic contact dermatitis: a case report

Thumbnail

D2.35 - Prevalence of the sensitivity to aeroallergens among patients with asthma and allergic rhinitis (AR), based on skin prick test (SPT) and its seasonal variation

Thumbnail

D2.36 - Clinical Outcomes Of Dental Procedures In Patients With Hereditary Angioedema

Thumbnail

D2.37 - Prevalence of food cross-sensitization due to PR-10 proteins among patients of different age groups

Thumbnail

D2.38 - Clinical Evaluation of Alternaria alternata Extract Used for Skin Prick Test in Diagnosis of Alternaria alternata Allergy

Thumbnail

D2.39 - Diagnostic performance of IgE sensitization with Blomia tropicalis for prediction of positive nasal challenge test

Thumbnail

D2.42 - Clinical relevance of secondary sensitizations to indoor allergens in patients with persistent allergic rhinitis in a region with high prevalence of dust mite allergy

Thumbnail

D2.43 - Implementation of the New Italian Health Care Price List: Impact on Allergy Diagnostics

Thumbnail

D2.44 - Kiwi Allergy in Singaporean Children

Thumbnail

D2.45 - Specific IgE for inhalant allergens: A cutoff of 0.35 kUA/L is too low

Thumbnail

D2.46 - Prevalence and prognosis of food allergies after liver transplantation in children

Thumbnail

D3.419 - Prevalence of physical urticaria hives in patients with systemic mastocytosis and their relation to disease course – preliminary data

Thumbnail

D3.411 - Targeting MRGPRX2 for the Treatment of Mast Cell-Driven Diseases

Thumbnail

D3.412 - MRGPRX2 Specific Activation Signature is Enriched in Atopic Dermatitis Lesions and Wheals from Chronic Spontaneous Urticaria Compared to Adjacent Healthy Skin

Thumbnail

D3.413 - Development of the Mastocytosis Symptom Severity Daily Diary (MS2D2) for Non-Advanced Systemic Mastocytosis (NonAdvSM) Patients and Establishing Content Validity

Thumbnail

D3.414 - The Phase 2/3 Study of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis